Top 200 Biopharmaceuticals Industry Report Global

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Search ReportLinker

The Largest Collection of Market Research Reports

» 1.2 Million Industry Reports
» 450,000 Company Profiles
» 850,000 Market Briefings
» 40,000 Country Guides

From +200,000 authoritative sources

DOWNLOAD THESE REPORTS NOW!

Global Vaccine Market

Global Vaccine Market

  • $ 652
  • Industry report
  • by Global Research & Data Services
  • May 2013
  • 19 pages

This market research report offers a perspective on the actual market situation, trends and future outlook for vaccines in the world. The study provides essential market information for decision-makers including: - Overall market for vaccines in the world - Market for vaccines by type - Forecasts and ...

Industries: Biopharmaceutical | Countries: World

Crucell N.V. - Strategic SWOT Analysis Review

Crucell N.V. - Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • by Global Data
  • May 2013
  • 28 pages

Summary Crucell N.V. (Crucell) is a biopharmaceutical company. It discovers, develops, manufactures and markets vaccines and antibodies indicated against infectious diseases. Its product portfolio comprises marketed products, vaccines under development and development stage antibodies. The company's ...

Industries: Biopharmaceutical | Countries: World

Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors

Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors

  • $ 2 064
  • Industry report
  • by La Merie Publishing
  • May 2013
  • 301 pages

Product Description The new Competitive Intelligence Report Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors of May 2013 provides a competitor analysis of the product portfolios and development pipelines of ten major classes of therapeutic proteins and their biosimilar and biobet ...

Industries: Biopharmaceutical | Countries: South Korea, India, China, World

Competitor Analysis: Erythropoiesis Stimulating Agents (ESA)

Competitor Analysis: Erythropoiesis Stimulating Agents (ESA)

  • $ 645
  • Industry report
  • by La Merie Publishing
  • April 2013
  • 94 pages

Product description The Competitive Intelligence Report Erythropoiesis Stimulating Agents (ESA) as of April 2013 provides information on existing first and second generation epoetin products in regulated markets, an overview on biosimilar versions of erythropoietin (EPO) in regulated markets, a compilation ...

Industries: Biopharmaceutical | Countries: World

Protein Engineering Market [Products (Monoclonal Antibody, Insulin Analog, Modified EPO), Technology (Sequential Modification, Glycosylation, PEGylation), and Applications (Therapeutics, Diagnostics, Research)] - Global Forecast to 2017

Protein Engineering Market [Products (Monoclonal Antibody, Insulin Analog, Modified EPO), Technology (Sequential Modification, Glycosylation, PEGylation), and Applications (Therapeutics, Diagnostics, Research)] - Global Forecast to 2017

  • $ 4 650
  • Industry report
  • by MarketsandMarkets
  • March 2013
  • 148 pages

Proteins exhibit high specificity and less immunogenicity and are widely used as therapeutic agents in the treatment of various disorders and diseases. There are more than 200 protein-based products currently being marketed; 90% of them are used as therapeutics. In order to improve their clinical potential, ...

Industries: Biopharmaceutical | Countries: World

World Biopharmaceutical: Growth Hormone Deficiency - Pipeline Review, H1 2012

World Biopharmaceutical: Growth Hormone Deficiency - Pipeline Review, H1 2012

  • $ 2 000
  • Company report
  • by Global Markets Direct
  • March 2013
  • 91 pages

This report provides data on the therapeutic development for Growth Hormone Deficiency, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Growth Hormone Deficiency. 'Growth Hormone Deficiency ...

Industries: Biopharmaceutical | Countries: World, United States

Global Industrial Enzymes Market 2012-2016

Global Industrial Enzymes Market 2012-2016

  • $ 2 000
  • Industry report
  • by Infiniti Research Limited
  • March 2013
  • 33 pages

TechNavio's analysts forecast the Global Industrial Enzymes market to grow at a CAGR of 7.49 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increase in the end-user applications of industrial enzymes. The Global Industrial Enzymes market has also been ...

Industries: Biopharmaceutical | Countries: World

Chikungunya - Pipeline Review, H1 2013

Chikungunya - Pipeline Review, H1 2013

  • $ 2 000
  • Industry report
  • by Global Markets Direct
  • February 2013
  • 40 pages

Chikungunya - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Chikungunya - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Chikungunya, complete with latest updates, and special ...

Industries: Biopharmaceutical | Countries: World, United States

Monoclonal Antibodies Market in Rheumatoid Arthritis to 2018 - Market Characterized by Large and Diversified Pipeline and Low Threat of Biosimilar Sales Erosion

Monoclonal Antibodies Market in Rheumatoid Arthritis to 2018 - Market Characterized by Large and Diversified Pipeline and Low Threat of Biosimilar Sales Erosion

  • $ 3 500
  • Industry report
  • by GBI Research
  • January 2013
  • 134 pages

Monoclonal Antibodies Market in Rheumatoid Arthritis to 2018 - Market Characterized by Large and Diversified Pipeline and Low Threat of Biosimilar Sales Erosion Summary GBI Research, the leading business intelligence provider, has released its latest research, ?Monoclonal Antibodies Market in Rheumatoid ...

Industries: Biopharmaceutical | Countries: World

NovImmune SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile

NovImmune SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • by Global Data
  • January 2013
  • 17 pages

Summary NovImmune SA (NovImmune) is a biotechnology company, based in Switzerland. It discovers and develops therapeutic monoclonal antibodies for the treatment of immune-related disorders and inflammatory diseases. The company's products include NI-0801, NI-0401, NI-0701, NI-0501, NI-1401, NI-0101, ...

Industries: Biopharmaceutical | Countries: Switzerland, Europe, World

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • (866) 682 9815

Privacy Policy by TRUSTe
ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.